Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
This study is designed to compare the effects of twice-daily exenatide plus oral antidiabetic (OAD) agents and twice-daily placebo plus OAD with respect to glycemic control, as measured by hemoglobin A1c (HbA1c), in patients with type 2 diabetes who experience inadequate glycemic control with OAD alone.
Epistemonikos ID: 9153da9ebc10565db9db301486081a767c05a993
First added on: May 04, 2024